NCT03341832View on ClinicalTrials.gov

Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

91

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

January 15, 2019

Study Completion Date

January 15, 2019

Conditions

Acute Low Back Pain

Interventions

DRUG

NVP-1203

oral dose for 7 days

DRUG

NVP-1203-R

oral dose for 7 days

DRUG

NVP-1203 placebo

oral dose for 7 days

DRUG

NVP-1203-R placebo

oral dose for 7 days

Trial Locations (1)

16209

Navipharm, Suwon

Sponsors

Lead Sponsor

All Listed Sponsors

lead

NVP Healthcare

INDUSTRY